A Prediction Model with a Combination of Variables for Diagnosis of Lung Cancer
- PMID: 29176545
- PMCID: PMC5713113
- DOI: 10.12659/msm.904738
A Prediction Model with a Combination of Variables for Diagnosis of Lung Cancer
Abstract
BACKGROUND Multivariate models with a combination of variables can predict disease more accurately than a single variable employed alone. We developed a logistic regression model with a combination of variables and evaluated its ability to predict lung cancer. MATERIAL AND METHODS The exhaled breath from 57 patients with lung cancer and 72 healthy controls without cancer was collected. The VOCs of exhaled breath were examined qualitatively and quantitatively by a novel electronic nose (Z-nose4200 equipment). The VOCs in the 2 groups were compared using the Mann-Whitney U test, and the baseline data were compared between the 2 groups using the chi-square test or ANOVA. Variables from VOCs and baseline data were selected by stepwise logistic regression and subjected to a prediction model for the diagnosis of lung cancer as combined factors. The receiver operating characteristic (ROC) curve was used to evaluate the predictive ability of this prediction model. RESULTS Nine VOCs in exhaled breath of lung cancer patients differed significantly from those of healthy controls. Four variables - age, hexane, 2,2,4,6,6-pentamethylheptane, and 1,2,6-trimethylnaphthalene - were entered into the prediction model, which could effectively separate the lung cancer samples from the control samples with an accuracy of 82.8%, a sensitivity of 76.0%, and a specificity of 94.0%. CONCLUSIONS The profile of VOCs in exhaled breath contained distinguishable biomarkers in the patients with lung cancers. The prediction model with 4 variables appears to provide a new technique for lung cancer detection.
Conflict of interest statement
None.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5713113/bin/medscimonit-23-5620-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5713113/bin/medscimonit-23-5620-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5713113/bin/medscimonit-23-5620-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5713113/bin/medscimonit-23-5620-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5713113/bin/medscimonit-23-5620-g005.gif)
Similar articles
-
Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.Cancer Biomark. 2017 Dec 12;21(1):29-39. doi: 10.3233/CBM-170177. Cancer Biomark. 2017. PMID: 29060925 Review.
-
Detection of cancer through exhaled breath: a systematic review.Oncotarget. 2015 Nov 17;6(36):38643-57. doi: 10.18632/oncotarget.5938. Oncotarget. 2015. PMID: 26440312 Free PMC article. Review.
-
Breath carbonyl compounds as biomarkers of lung cancer.Lung Cancer. 2015 Oct;90(1):92-7. doi: 10.1016/j.lungcan.2015.07.005. Epub 2015 Jul 19. Lung Cancer. 2015. PMID: 26233567
-
The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.Cancer Biomark. 2012;11(4):129-37. doi: 10.3233/CBM-2012-00270. Cancer Biomark. 2012. PMID: 23144150
-
Detection of lung cancer using weighted digital analysis of breath biomarkers.Clin Chim Acta. 2008 Jul 17;393(2):76-84. doi: 10.1016/j.cca.2008.02.021. Epub 2008 Mar 3. Clin Chim Acta. 2008. PMID: 18420034 Free PMC article.
Cited by
-
A combined screening study for evaluating the potential of exhaled acetone, isoprene, and nitric oxide as biomarkers of lung cancer.RSC Adv. 2023 Oct 30;13(45):31835-31843. doi: 10.1039/d3ra04522f. eCollection 2023 Oct 26. RSC Adv. 2023. PMID: 37908654 Free PMC article.
-
Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules.Chest. 2023 Oct;164(4):1028-1041. doi: 10.1016/j.chest.2023.05.025. Epub 2023 May 25. Chest. 2023. PMID: 37244587 Review.
-
Development and validation of a nomogram model for lung cancer based on radiomics artificial intelligence score and clinical blood test data.Front Oncol. 2023 Mar 29;13:1132514. doi: 10.3389/fonc.2023.1132514. eCollection 2023. Front Oncol. 2023. PMID: 37064148 Free PMC article.
-
Urinary Volatiles and Chemical Characterisation for the Non-Invasive Detection of Prostate and Bladder Cancers.Biosensors (Basel). 2021 Nov 3;11(11):437. doi: 10.3390/bios11110437. Biosensors (Basel). 2021. PMID: 34821653 Free PMC article.
-
Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD.J Clin Med. 2020 Dec 24;10(1):32. doi: 10.3390/jcm10010032. J Clin Med. 2020. PMID: 33374433 Free PMC article. Review.
References
-
- Jemal A. Global cancer statistics. Cancer J Clin. 2011;61(2):69–90. Erratum in: Cancer J Clin, 2011; 61(2): 134. - PubMed
-
- Tarver T. Cancer facts & figures 2012. American Cancer Society (ACS) Journal of Consumer Health on the Internet. 2012;16:366–67.
-
- Todd J, Mcgrath EE. Chest X-ray mass in a patient with lung cancer! QJM. 2011;104:903–4. - PubMed